EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

DOCK11 promotes HBV cccDNA formation through a PARP1-dependent mechanism

Hideo Takayama iD, Kouki Nio iD, Kazuyuki Kuroki, Ying-Yi Li, Saiho Sugimoto, Tetsuro Shimakami, Kazuhisa Murai, Kazunori Kawaguchi, Takumi Nishiuchi, Shuichi Kaneko, Masao Honda, Taro Yamashita

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.04140-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Hideo Takayama und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan. Hauptthemen laut MEDLINE: Poly (ADP-Ribose) Polymerase-1, Hepatitis B virus, DNA, Circular, DNA, Viral. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis B virus (HBV) infection remains a major global health concern due to the persistence of covalently closed circular DNA (cccDNA) in the hepatocyte nucleus, which contributes to viral persistence and hepatocarcinogenesis despite antiviral therapy. Poly(ADP-ribose) polymerase 1 (PARP1) has been reported to bind to HBV relaxed circular DNA (rcDNA) and contribute to the conversion of rcDNA to cccDNA. We previously identified dedicator of cytokinesis 11 (DOCK11) as a host factor whose suppression reduced cccDNA levels in HBV infection models; however, the precise role of DOCK11 in the process of cccDNA formation remains unclear. In this study, we investigated the role of DOCK11 in HBV cccDNA formation and the underlying mechanisms. Using a minicircle HBV cccDNA reporter, we observed that luciferase activity declined significantly in DOCK11-depleted hepatoma cells over time, consistent with impaired cccDNA maintenance. In a cell-free assay using rcDNA and nuclear extracts, DOCK11 overexpression significantly enhanced cccDNA formation, while DOCK11 knockout significantly suppressed it. Co-immunoprecipitation suggested that DOCK11 forms a multiprotein complex with HBV DNA. Furthermore, liquid chromatography-mass spectrometry analysis identified PARP1 as a significant component of this complex. Notably, while DOCK11 did not affect PARP1 expression or enzymatic activity, DOCK11 knockout significantly reduced PARP1 recruitment to UV-irradiated DNA damage sites and its association with rcDNA, suggesting a supportive role for DOCK11 in PARP1 recruitment to rcDNA. In summary, DOCK11 promotes HBV cccDNA formation, possibly through its interaction with HBV DNA and PARP1. These findings position DOCK11 as a promising therapeutic target for cccDNA reduction in chronic HBV infection. IMPORTANCE Hepatitis B virus (HBV) causes chronic liver infection, affecting hundreds of millions of people worldwide and increasing the risk of cirrhosis and hepatocellular carcinoma. Persistent HBV infection is maintained by covalently closed circular DNA (cccDNA), which is resistant to current antiviral therapies. Understanding cccDNA maintenance mechanisms, including cccDNA formation, is therefore critical for developing curative treatments. Poly(ADP-ribose) polymerase 1 (PARP1) is known to bind HBV relaxed circular DNA (rcDNA) and contribute to the conversion of rcDNA to cccDNA. In this study, we identified the host protein dedicator of cytokinesis 11 as a host regulator of HBV cccDNA formation through its interaction with PARP1, an enzyme involved in DNA repair. Our findings reveal a previously unrecognized mechanism by which HBV exploits host cellular machinery to persist in hepatocytes. By inhibiting this pathway, our work highlights potential targets for novel therapies aimed at eliminating cccDNA and achieving a functional cure for HBV infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Poly (ADP-Ribose) Polymerase-1Hepatitis B virusDNA, CircularDNA, ViralGuanine Nucleotide Exchange FactorsHepatitis BHumansVirus ReplicationHepatocytesHost-Pathogen InteractionsCell Line, Tumor

Stichwörter der Autor:innen

DNA repairDOCK11PARP1cccDNAcccDNA formationhepatitis B virusrcDNA

Substanzen

Poly (ADP-Ribose) Polymerase-1DNA, CircularPARP1 protein, humanDNA, ViralGuanine Nucleotide Exchange Factors

Autor:innen und Institutionen

  • Department of Gastroenterology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • Department of Clinical Laboratory Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • Division of Life Science, Graduate School of Natural Science and Technology, Kanazawa University, Kanazawa, Japan.

ORCID-Profile: Hideo Takayama, Kouki Nio

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Takayama, H., Nio, K., Kuroki, K., Li, Y. Y., Sugimoto, S., Shimakami, T., Murai, K., Kawaguchi, K., Nishiuchi, T., Kaneko, S., Honda, M., & Yamashita, T. (2026). DOCK11 promotes HBV cccDNA formation through a PARP1-dependent mechanism. Microbiology Spectrum. https://doi.org/10.1128/spectrum.04140-25

Vancouver

Takayama H, Nio K, Kuroki K, Li YY, Sugimoto S, Shimakami T, et al. DOCK11 promotes HBV cccDNA formation through a PARP1-dependent mechanism. Microbiology Spectrum. 2026. doi:10.1128/spectrum.04140-25

BibTeX
@article{Takayama2026,
  author = {Takayama, Hideo and Nio, Kouki and Kuroki, Kazuyuki and Li, Ying-Yi and Sugimoto, Saiho and Shimakami, Tetsuro and Murai, Kazuhisa and Kawaguchi, Kazunori and Nishiuchi, Takumi and Kaneko, Shuichi and Honda, Masao and Yamashita, Taro},
  title = {DOCK11 promotes HBV cccDNA formation through a PARP1-dependent mechanism},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.04140-25}
}
Kostenlos starten →